NO318143B1 - Substituerte cyklobutylamin-derivater samt farmasoytisk preparat - Google Patents
Substituerte cyklobutylamin-derivater samt farmasoytisk preparat Download PDFInfo
- Publication number
- NO318143B1 NO318143B1 NO19995839A NO995839A NO318143B1 NO 318143 B1 NO318143 B1 NO 318143B1 NO 19995839 A NO19995839 A NO 19995839A NO 995839 A NO995839 A NO 995839A NO 318143 B1 NO318143 B1 NO 318143B1
- Authority
- NO
- Norway
- Prior art keywords
- compound
- salt
- fluoro
- hydrates
- group
- Prior art date
Links
- 239000000825 pharmaceutical preparation Chemical class 0.000 title claims description 6
- KZZKOVLJUKWSKX-UHFFFAOYSA-N cyclobutanamine Chemical class NC1CCC1 KZZKOVLJUKWSKX-UHFFFAOYSA-N 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims description 132
- 150000003839 salts Chemical class 0.000 claims description 44
- -1 5-amino-3-carboxy-6-fluoro-1-[2-(S)-fluoro-1-(R)-cyclopropyl]-1,4-dihydro-8 -methyl-4-oxoquinolin-7-yl group Chemical group 0.000 claims description 39
- 150000004677 hydrates Chemical class 0.000 claims description 34
- 125000004432 carbon atom Chemical group C* 0.000 claims description 18
- 125000005843 halogen group Chemical group 0.000 claims description 17
- 125000001424 substituent group Chemical group 0.000 claims description 17
- 229910052731 fluorine Inorganic materials 0.000 claims description 15
- 125000001153 fluoro group Chemical group F* 0.000 claims description 15
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 125000003277 amino group Chemical group 0.000 claims description 7
- 125000006165 cyclic alkyl group Chemical group 0.000 claims description 3
- MENSSOHGBIRROR-HEVMSJOKSA-N 5-amino-7-[3-(1-amino-3,3-difluorocyclobutyl)pyrrolidin-1-yl]-6-fluoro-1-[(1r,2s)-2-fluorocyclopropyl]-8-methyl-4-oxoquinoline-3-carboxylic acid Chemical group FC1=C(N)C(C(C(C(O)=O)=CN2[C@H]3[C@H](C3)F)=O)=C2C(C)=C1N(C1)CCC1C1(N)CC(F)(F)C1 MENSSOHGBIRROR-HEVMSJOKSA-N 0.000 claims description 2
- GEBGQJFHSUAVMX-JFNZQFHQSA-N 5-amino-7-[3-(1-amino-3-fluorocyclobutyl)pyrrolidin-1-yl]-6,8-difluoro-1-[(1r,2s)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid Chemical group FC=1C=2N([C@H]3[C@H](C3)F)C=C(C(O)=O)C(=O)C=2C(N)=C(F)C=1N(C1)CCC1C1(N)CC(F)C1 GEBGQJFHSUAVMX-JFNZQFHQSA-N 0.000 claims description 2
- GTLFEFKIVGAPDH-GOYITYAMSA-N 5-amino-7-[3-(1-amino-3-fluorocyclobutyl)pyrrolidin-1-yl]-6-fluoro-1-[(1r,2s)-2-fluorocyclopropyl]-8-methyl-4-oxoquinoline-3-carboxylic acid Chemical group FC1=C(N)C(C(C(C(O)=O)=CN2[C@H]3[C@H](C3)F)=O)=C2C(C)=C1N(C1)CCC1C1(N)CC(F)C1 GTLFEFKIVGAPDH-GOYITYAMSA-N 0.000 claims description 2
- PWUNIVDYHDVCHN-RVFBMXNDSA-N 7-[3-(1-amino-3-fluorocyclobutyl)pyrrolidin-1-yl]-6-fluoro-1-[(1r,2s)-2-fluorocyclopropyl]-8-methoxy-4-oxoquinoline-3-carboxylic acid Chemical group FC1=CC(C(C(C(O)=O)=CN2[C@H]3[C@H](C3)F)=O)=C2C(OC)=C1N(C1)CCC1C1(N)CC(F)C1 PWUNIVDYHDVCHN-RVFBMXNDSA-N 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 description 96
- 239000000243 solution Substances 0.000 description 90
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 88
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 87
- 238000003756 stirring Methods 0.000 description 72
- 239000010410 layer Substances 0.000 description 62
- 239000002904 solvent Substances 0.000 description 62
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 55
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 55
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 51
- 239000012044 organic layer Substances 0.000 description 49
- 238000006243 chemical reaction Methods 0.000 description 42
- 238000001816 cooling Methods 0.000 description 40
- 238000001914 filtration Methods 0.000 description 40
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 36
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 33
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 28
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 27
- 238000010898 silica gel chromatography Methods 0.000 description 27
- 238000005160 1H NMR spectroscopy Methods 0.000 description 26
- 239000000203 mixture Substances 0.000 description 26
- 229920006395 saturated elastomer Polymers 0.000 description 26
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 21
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
- 238000000926 separation method Methods 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 20
- 230000000694 effects Effects 0.000 description 19
- 239000011541 reaction mixture Substances 0.000 description 19
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- 238000001704 evaporation Methods 0.000 description 18
- 230000008020 evaporation Effects 0.000 description 18
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 17
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 17
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- 238000000746 purification Methods 0.000 description 15
- 239000003054 catalyst Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 14
- 230000000844 anti-bacterial effect Effects 0.000 description 13
- 235000017557 sodium bicarbonate Nutrition 0.000 description 13
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 13
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 10
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 10
- 239000001257 hydrogen Substances 0.000 description 10
- 239000012299 nitrogen atmosphere Substances 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 238000005481 NMR spectroscopy Methods 0.000 description 9
- 125000006239 protecting group Chemical group 0.000 description 9
- 238000010992 reflux Methods 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- HEMHJVSKTPXQMS-DYCDLGHISA-M Sodium hydroxide-d Chemical compound [Na+].[2H][O-] HEMHJVSKTPXQMS-DYCDLGHISA-M 0.000 description 8
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 239000013078 crystal Substances 0.000 description 7
- 238000000921 elemental analysis Methods 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 238000012746 preparative thin layer chromatography Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 229940072132 quinolone antibacterials Drugs 0.000 description 6
- 238000001953 recrystallisation Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 239000005909 Kieselgur Substances 0.000 description 5
- 239000007868 Raney catalyst Substances 0.000 description 5
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 5
- 229910000564 Raney nickel Inorganic materials 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- GKIRPKYJQBWNGO-OCEACIFDSA-N clomifene Chemical compound C1=CC(OCCN(CC)CC)=CC=C1C(\C=1C=CC=CC=1)=C(\Cl)C1=CC=CC=C1 GKIRPKYJQBWNGO-OCEACIFDSA-N 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 239000012046 mixed solvent Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- WADSJYLPJPTMLN-UHFFFAOYSA-N 3-(cycloundecen-1-yl)-1,2-diazacycloundec-2-ene Chemical compound C1CCCCCCCCC=C1C1=NNCCCCCCCC1 WADSJYLPJPTMLN-UHFFFAOYSA-N 0.000 description 4
- JUSOWTKVZJDEDG-IONNQARKSA-N 6,7-difluoro-1-[(1r,2s)-2-fluorocyclopropyl]-8-methoxy-4-oxoquinoline-3-carboxylic acid Chemical compound COC1=C(F)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2[C@@H]1C[C@@H]1F JUSOWTKVZJDEDG-IONNQARKSA-N 0.000 description 4
- 206010028470 Mycoplasma infections Diseases 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 4
- 239000013522 chelant Substances 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 150000002148 esters Chemical group 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- LRSGOFJOUOCNPM-UHFFFAOYSA-N tert-butyl n-(3,3-difluoro-1-pyrrolidin-3-ylcyclobutyl)carbamate Chemical compound C1CNCC1C1(NC(=O)OC(C)(C)C)CC(F)(F)C1 LRSGOFJOUOCNPM-UHFFFAOYSA-N 0.000 description 4
- SCYISQGCBWOPPY-UHFFFAOYSA-N tert-butyl n-(3-fluoro-1-pyrrolidin-3-ylcyclobutyl)carbamate Chemical compound C1CNCC1C1(NC(=O)OC(C)(C)C)CC(F)C1 SCYISQGCBWOPPY-UHFFFAOYSA-N 0.000 description 4
- YSLIPUSJNFIFAB-UHFFFAOYSA-N 2-oxopyridine-1-carboxylic acid Chemical group OC(=O)N1C=CC=CC1=O YSLIPUSJNFIFAB-UHFFFAOYSA-N 0.000 description 3
- LIFSIBVTJOPWMV-NKWVEPMBSA-N 5-amino-6,7-difluoro-1-[(1r,2s)-2-fluorocyclopropyl]-8-methyl-4-oxoquinoline-3-carboxylic acid Chemical compound CC1=C(F)C(F)=C(N)C(C(C(C(O)=O)=C2)=O)=C1N2[C@@H]1C[C@@H]1F LIFSIBVTJOPWMV-NKWVEPMBSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 241000271566 Aves Species 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 3
- 206010039438 Salmonella Infections Diseases 0.000 description 3
- 206010040047 Sepsis Diseases 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 3
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- 201000003146 cystitis Diseases 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 206010039447 salmonellosis Diseases 0.000 description 3
- 239000012266 salt solution Substances 0.000 description 3
- OESYEQKYGJSQHF-UHFFFAOYSA-N tert-butyl n-[1-(1-benzyl-5-oxopyrrolidin-3-yl)-3-hydroxycyclobutyl]carbamate Chemical compound C1N(CC=2C=CC=CC=2)C(=O)CC1C1(NC(=O)OC(C)(C)C)CC(O)C1 OESYEQKYGJSQHF-UHFFFAOYSA-N 0.000 description 3
- TUKJTSUSKQOYCD-STHAYSLISA-N (1r,2s)-2-fluorocyclopropan-1-amine Chemical compound N[C@@H]1C[C@@H]1F TUKJTSUSKQOYCD-STHAYSLISA-N 0.000 description 2
- AKYSEPDNPPKSTE-UHFFFAOYSA-N 1-(3-methylbutoxycarbonyl)-3-phenylmethoxycyclobutane-1-carboxylic acid Chemical compound C1C(C(=O)OCCC(C)C)(C(O)=O)CC1OCC1=CC=CC=C1 AKYSEPDNPPKSTE-UHFFFAOYSA-N 0.000 description 2
- RLNGOJBRPDTXQM-UHFFFAOYSA-N 1-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylmethoxycyclobutane-1-carboxylic acid Chemical compound C1C(NC(=O)OC(C)(C)C)(C(O)=O)CC1OCC1=CC=CC=C1 RLNGOJBRPDTXQM-UHFFFAOYSA-N 0.000 description 2
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 101150041968 CDC13 gene Proteins 0.000 description 2
- 208000003322 Coinfection Diseases 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- 206010061190 Haemophilus infection Diseases 0.000 description 2
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 2
- 241000204031 Mycoplasma Species 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 150000007514 bases Chemical class 0.000 description 2
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 2
- 229940073608 benzyl chloride Drugs 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000010531 catalytic reduction reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002008 hemorrhagic effect Effects 0.000 description 2
- 150000002431 hydrogen Chemical group 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- NWELDCIRFBARNC-UHFFFAOYSA-L magnesium;2-ethylpropanedioate Chemical compound [Mg+2].CCC(C([O-])=O)C([O-])=O NWELDCIRFBARNC-UHFFFAOYSA-L 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 2
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 2
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 2
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000000651 prodrug Substances 0.000 description 2
- 229940002612 prodrug Drugs 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 2
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- MWGBLZSKOYFTGP-UHFFFAOYSA-N tert-butyl n-[1-(1-benzyl-5-oxopyrrolidin-3-yl)-3,3-difluorocyclobutyl]carbamate Chemical compound C1N(CC=2C=CC=CC=2)C(=O)CC1C1(NC(=O)OC(C)(C)C)CC(F)(F)C1 MWGBLZSKOYFTGP-UHFFFAOYSA-N 0.000 description 2
- RTZWTUMLPNXNRL-UHFFFAOYSA-N tert-butyl n-[1-(1-benzyl-5-oxopyrrolidin-3-yl)-3-fluorocyclobutyl]carbamate Chemical compound C1N(CC=2C=CC=CC=2)C(=O)CC1C1(NC(=O)OC(C)(C)C)CC(F)C1 RTZWTUMLPNXNRL-UHFFFAOYSA-N 0.000 description 2
- BGSVPXZRLIQIEB-UHFFFAOYSA-N tert-butyl n-[1-(1-benzyl-5-oxopyrrolidin-3-yl)-3-oxocyclobutyl]carbamate Chemical compound C1N(CC=2C=CC=CC=2)C(=O)CC1C1(NC(=O)OC(C)(C)C)CC(=O)C1 BGSVPXZRLIQIEB-UHFFFAOYSA-N 0.000 description 2
- UZNJENKPKYRNBX-UHFFFAOYSA-N tert-butyl n-[1-(1-benzylpyrrolidin-3-yl)-3,3-difluorocyclobutyl]carbamate Chemical compound C1CN(CC=2C=CC=CC=2)CC1C1(NC(=O)OC(C)(C)C)CC(F)(F)C1 UZNJENKPKYRNBX-UHFFFAOYSA-N 0.000 description 2
- MTDDMUKLCIQXCT-UHFFFAOYSA-N tert-butyl n-[1-(1-benzylpyrrolidin-3-yl)-3-fluorocyclobutyl]carbamate Chemical compound C1CN(CC=2C=CC=CC=2)CC1C1(NC(=O)OC(C)(C)C)CC(F)C1 MTDDMUKLCIQXCT-UHFFFAOYSA-N 0.000 description 2
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000000037 tert-butyldiphenylsilyl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1[Si]([H])([*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Chemical class OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical class CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 1
- JSGVZVOGOQILFM-UHFFFAOYSA-N 3-methoxy-1-butanol Chemical compound COC(C)CCO JSGVZVOGOQILFM-UHFFFAOYSA-N 0.000 description 1
- YOTJTEBKPSRUGO-UHFFFAOYSA-N 3-methylbutyl 1-(3-ethoxy-1-hydroxy-3-oxopropyl)-3-phenylmethoxycyclobutane-1-carboxylate Chemical compound C1C(C(O)CC(=O)OCC)(C(=O)OCCC(C)C)CC1OCC1=CC=CC=C1 YOTJTEBKPSRUGO-UHFFFAOYSA-N 0.000 description 1
- WXGDCBKUKZFBQS-UHFFFAOYSA-N 3-methylbutyl 1-(3-ethoxy-3-oxopropanoyl)-3-phenylmethoxycyclobutane-1-carboxylate Chemical compound C1C(C(=O)CC(=O)OCC)(C(=O)OCCC(C)C)CC1OCC1=CC=CC=C1 WXGDCBKUKZFBQS-UHFFFAOYSA-N 0.000 description 1
- OLMHJAQRODKBAS-UHFFFAOYSA-N 3-methylbutyl 1-(4-ethoxy-1-nitro-4-oxobutan-2-yl)-3-phenylmethoxycyclobutane-1-carboxylate Chemical compound C1C(C(C[N+]([O-])=O)CC(=O)OCC)(C(=O)OCCC(C)C)CC1OCC1=CC=CC=C1 OLMHJAQRODKBAS-UHFFFAOYSA-N 0.000 description 1
- UXGVNJYAUWAGPC-UHFFFAOYSA-N 3-methylbutyl 1-(5-oxopyrrolidin-3-yl)-3-phenylmethoxycyclobutane-1-carboxylate Chemical compound C1C(C(=O)OCCC(C)C)(C2CC(=O)NC2)CC1OCC1=CC=CC=C1 UXGVNJYAUWAGPC-UHFFFAOYSA-N 0.000 description 1
- VIJWUBALWIFLIF-ZRDIBKRKSA-N 3-methylbutyl 1-[(e)-3-ethoxy-3-oxoprop-1-enyl]-3-phenylmethoxycyclobutane-1-carboxylate Chemical compound C1C(/C=C/C(=O)OCC)(C(=O)OCCC(C)C)CC1OCC1=CC=CC=C1 VIJWUBALWIFLIF-ZRDIBKRKSA-N 0.000 description 1
- IUCOXSUWLDYEMW-HQPFYNDMSA-N 7-[3-(1-amino-3,3-difluorocyclobutyl)pyrrolidin-1-yl]-6-fluoro-1-[(1r,2s)-2-fluorocyclopropyl]-8-methoxy-4-oxoquinoline-3-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=CN2[C@H]3[C@H](C3)F)=O)=C2C(OC)=C1N(C1)CCC1C1(N)CC(F)(F)C1 IUCOXSUWLDYEMW-HQPFYNDMSA-N 0.000 description 1
- BWJHJLINOYAPEG-HOTGVXAUSA-N 8-chloro-6-[(6-chloropyridin-3-yl)methyl]-3-[(1S,2S)-2-hydroxycyclopentyl]-7-methyl-2H-1,3-benzoxazin-4-one Chemical compound ClC1=C(C(=CC=2C(N(COC=21)[C@@H]1[C@H](CCC1)O)=O)CC=1C=NC(=CC=1)Cl)C BWJHJLINOYAPEG-HOTGVXAUSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical class CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000589291 Acinetobacter Species 0.000 description 1
- 206010000501 Acne conglobata Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 201000008283 Atrophic Rhinitis Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 206010004142 Bartholinitis Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 241000588807 Bordetella Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 208000031462 Bovine Mastitis Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 206010006448 Bronchiolitis Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- LQIKBPYBZLAILZ-UHFFFAOYSA-N C1N(CC=2C=CC=CC=2)C(=O)CC1C1(C(=O)O)CC(F)C1 Chemical compound C1N(CC=2C=CC=CC=2)C(=O)CC1C1(C(=O)O)CC(F)C1 LQIKBPYBZLAILZ-UHFFFAOYSA-N 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 208000014085 Chronic respiratory disease Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical class [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000588923 Citrobacter Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011844 Dacryocystitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010014568 Empyema Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 206010016936 Folliculitis Diseases 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical class OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 206010056254 Intrauterine infection Diseases 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical class CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical class NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical class CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 206010034107 Pasteurella infections Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000191992 Peptostreptococcus Species 0.000 description 1
- 208000009019 Pericoronitis Diseases 0.000 description 1
- 206010052814 Perirectal abscess Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 206010039088 Rhinitis atrophic Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 206010042343 Subcutaneous abscess Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 206010064996 Ulcerative keratitis Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- SORGEQQSQGNZFI-UHFFFAOYSA-N [azido(phenoxy)phosphoryl]oxybenzene Chemical compound C=1C=CC=CC=1OP(=O)(N=[N+]=[N-])OC1=CC=CC=C1 SORGEQQSQGNZFI-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical class [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 208000010217 blepharitis Diseases 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 201000009151 chronic rhinitis Diseases 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 201000007717 corneal ulcer Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 206010014665 endocarditis Diseases 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- HYLBKAZUEZUOMT-VAWYXSNFSA-N ethyl (e)-3-[1-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylmethoxycyclobutyl]prop-2-enoate Chemical compound C1C(/C=C/C(=O)OCC)(NC(=O)OC(C)(C)C)CC1OCC1=CC=CC=C1 HYLBKAZUEZUOMT-VAWYXSNFSA-N 0.000 description 1
- OMYXTZXPDVLERC-UHFFFAOYSA-N ethyl 1-(1-benzyl-5-oxopyrrolidin-3-yl)-3-fluorocyclobutane-1-carboxylate Chemical compound C1N(CC=2C=CC=CC=2)C(=O)CC1C1(C(=O)OCC)CC(F)C1 OMYXTZXPDVLERC-UHFFFAOYSA-N 0.000 description 1
- WUSYFUCLSBKIJB-UHFFFAOYSA-N ethyl 1-(1-benzyl-5-oxopyrrolidin-3-yl)-3-hydroxycyclobutane-1-carboxylate Chemical compound C1N(CC=2C=CC=CC=2)C(=O)CC1C1(C(=O)OCC)CC(O)C1 WUSYFUCLSBKIJB-UHFFFAOYSA-N 0.000 description 1
- WBZGDZIEAGBMTA-UHFFFAOYSA-N ethyl 3-[1-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylmethoxycyclobutyl]-3-oxopropanoate Chemical compound C1C(C(=O)CC(=O)OCC)(NC(=O)OC(C)(C)C)CC1OCC1=CC=CC=C1 WBZGDZIEAGBMTA-UHFFFAOYSA-N 0.000 description 1
- FSEWECIPKBDILT-UHFFFAOYSA-N ethyl 3-[1-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylmethoxycyclobutyl]-4-nitrobutanoate Chemical compound C1C(C(C[N+]([O-])=O)CC(=O)OCC)(NC(=O)OC(C)(C)C)CC1OCC1=CC=CC=C1 FSEWECIPKBDILT-UHFFFAOYSA-N 0.000 description 1
- QMNMIJPRALXOIK-UHFFFAOYSA-N ethyl 3-hydroxy-3-[1-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylmethoxycyclobutyl]propanoate Chemical compound C1C(C(O)CC(=O)OCC)(NC(=O)OC(C)(C)C)CC1OCC1=CC=CC=C1 QMNMIJPRALXOIK-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 208000020426 gonococcal urethritis Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000002557 hidradenitis Diseases 0.000 description 1
- 208000008025 hordeolum Diseases 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- ACKFDYCQCBEDNU-UHFFFAOYSA-J lead(2+);tetraacetate Chemical compound [Pb+2].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O ACKFDYCQCBEDNU-UHFFFAOYSA-J 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 206010025226 lymphangitis Diseases 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical class OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 125000005188 oxoalkyl group Chemical group 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 201000005115 pasteurellosis Diseases 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000003884 phenylalkyl group Chemical group 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 231100000018 phototoxicity Toxicity 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 208000008423 pleurisy Diseases 0.000 description 1
- 201000006509 pleuropneumonia Diseases 0.000 description 1
- 229920003217 poly(methylsilsesquioxane) Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- DJXNJVFEFSWHLY-UHFFFAOYSA-N quinoline-3-carboxylic acid Chemical compound C1=CC=CC2=CC(C(=O)O)=CN=C21 DJXNJVFEFSWHLY-UHFFFAOYSA-N 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- UDYFLDICVHJSOY-UHFFFAOYSA-N sulfur trioxide-pyridine complex Substances O=S(=O)=O.C1=CC=NC=C1 UDYFLDICVHJSOY-UHFFFAOYSA-N 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- OQGKMYIBMJVCAB-UHFFFAOYSA-N tert-butyl n-[1-(1-benzyl-5-oxopyrrolidin-3-yl)-3-phenylmethoxycyclobutyl]carbamate Chemical compound C1C(NC(=O)OC(C)(C)C)(C2CC(=O)N(CC=3C=CC=CC=3)C2)CC1OCC1=CC=CC=C1 OQGKMYIBMJVCAB-UHFFFAOYSA-N 0.000 description 1
- LGAGWUJGOMXMSU-UHFFFAOYSA-N tert-butyl n-[1-(5-oxopyrrolidin-3-yl)-3-phenylmethoxycyclobutyl]carbamate Chemical compound C1C(NC(=O)OC(C)(C)C)(C2CC(=O)NC2)CC1OCC1=CC=CC=C1 LGAGWUJGOMXMSU-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14139897 | 1997-05-30 | ||
| PCT/JP1998/002359 WO1998054169A1 (fr) | 1997-05-30 | 1998-05-28 | Derives substitues de la cyclobutylamine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO995839D0 NO995839D0 (no) | 1999-11-29 |
| NO995839L NO995839L (no) | 2000-01-28 |
| NO318143B1 true NO318143B1 (no) | 2005-02-07 |
Family
ID=15291079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19995839A NO318143B1 (no) | 1997-05-30 | 1999-11-29 | Substituerte cyklobutylamin-derivater samt farmasoytisk preparat |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6448266B1 (es) |
| EP (1) | EP0990654B1 (es) |
| JP (1) | JP4357598B2 (es) |
| KR (1) | KR100551462B1 (es) |
| CN (1) | CN1191245C (es) |
| AR (1) | AR012883A1 (es) |
| AT (1) | ATE378327T1 (es) |
| AU (1) | AU732175B2 (es) |
| BR (1) | BR9809702A (es) |
| CA (1) | CA2292580A1 (es) |
| DE (1) | DE69838716T2 (es) |
| DK (1) | DK0990654T3 (es) |
| ES (1) | ES2297885T3 (es) |
| ID (1) | ID23696A (es) |
| IL (1) | IL133123A (es) |
| MY (1) | MY119816A (es) |
| NO (1) | NO318143B1 (es) |
| RU (1) | RU2205829C2 (es) |
| WO (1) | WO1998054169A1 (es) |
| ZA (1) | ZA984527B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4669607B2 (ja) | 1997-09-15 | 2011-04-13 | ザ プロクター アンド ギャンブル カンパニー | 抗微生物キノロン類、その組成物およびその使用 |
| RU2270695C2 (ru) | 1999-03-17 | 2006-02-27 | Дайити Фармасьютикал Ко., Лтд. | Фармацевтическая композиция |
| US20040063754A1 (en) * | 2000-11-20 | 2004-04-01 | Hisashi Takahashi | Dehalogeno compounds |
| JP2004515549A (ja) | 2000-12-14 | 2004-05-27 | ザ プロクター アンド ギャンブル カンパニー | 抗微生物２−ピリドン類、その組成物と使用 |
| DE60113450T2 (de) | 2000-12-14 | 2006-07-13 | The Procter & Gamble Company, Cincinnati | Antimikrobielle chinolone |
| ES2402420T3 (es) * | 2003-09-29 | 2013-05-03 | Daiichi Sankyo Company, Limited | Derivado del ácido 8-cianoquinolonacarboxílico |
| DK2001862T3 (da) | 2006-03-28 | 2011-08-08 | Warner Chilcott Co Llc | Malatsalte og polymorfe af (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyklopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolincarboxylsyre |
| WO2007110835A2 (en) | 2006-03-28 | 2007-10-04 | The Procter & Gamble Company | A coupling process for preparing quinolone intermediates |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3685157D1 (de) * | 1985-06-26 | 1992-06-11 | Daiichi Seiyaku Co | Pyridoncarbonsaeurederivate. |
| JPH0827728A (ja) * | 1990-02-13 | 1996-01-30 | Sf Marina System Ab | ポンツーンの昇降案内装置 |
| JP3745433B2 (ja) | 1995-02-02 | 2006-02-15 | 第一製薬株式会社 | 複素環式化合物 |
| KR100389773B1 (ko) * | 1995-02-02 | 2003-10-23 | 다이이찌 세이야꾸 가부시기가이샤 | 헤테로사이클릭화합물 |
| JP4040091B2 (ja) * | 1995-11-22 | 2008-01-30 | 第一三共株式会社 | 置換アミノシクロアルキルピロリジン誘導体 |
-
1998
- 1998-05-27 ZA ZA984527A patent/ZA984527B/xx unknown
- 1998-05-27 MY MYPI98002358A patent/MY119816A/en unknown
- 1998-05-28 ES ES98921863T patent/ES2297885T3/es not_active Expired - Lifetime
- 1998-05-28 US US09/424,780 patent/US6448266B1/en not_active Expired - Fee Related
- 1998-05-28 CN CNB988078066A patent/CN1191245C/zh not_active Expired - Fee Related
- 1998-05-28 WO PCT/JP1998/002359 patent/WO1998054169A1/ja active IP Right Grant
- 1998-05-28 AU AU74539/98A patent/AU732175B2/en not_active Ceased
- 1998-05-28 BR BR9809702-4A patent/BR9809702A/pt not_active Application Discontinuation
- 1998-05-28 DE DE69838716T patent/DE69838716T2/de not_active Expired - Fee Related
- 1998-05-28 AT AT98921863T patent/ATE378327T1/de not_active IP Right Cessation
- 1998-05-28 DK DK98921863T patent/DK0990654T3/da active
- 1998-05-28 IL IL13312398A patent/IL133123A/en not_active IP Right Cessation
- 1998-05-28 EP EP98921863A patent/EP0990654B1/en not_active Expired - Lifetime
- 1998-05-28 CA CA002292580A patent/CA2292580A1/en not_active Abandoned
- 1998-05-28 RU RU99125325/04A patent/RU2205829C2/ru not_active IP Right Cessation
- 1998-05-28 KR KR1019997011191A patent/KR100551462B1/ko not_active IP Right Cessation
- 1998-05-28 ID IDW991489A patent/ID23696A/id unknown
- 1998-05-28 JP JP50048599A patent/JP4357598B2/ja not_active Expired - Fee Related
- 1998-05-29 AR ARP980102496A patent/AR012883A1/es active IP Right Grant
-
1999
- 1999-11-29 NO NO19995839A patent/NO318143B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO995839D0 (no) | 1999-11-29 |
| KR100551462B1 (ko) | 2006-02-14 |
| IL133123A0 (en) | 2001-03-19 |
| WO1998054169A1 (fr) | 1998-12-03 |
| ATE378327T1 (de) | 2007-11-15 |
| US6448266B1 (en) | 2002-09-10 |
| EP0990654A4 (en) | 2004-09-15 |
| ZA984527B (en) | 1998-12-03 |
| KR20010013204A (ko) | 2001-02-26 |
| AU7453998A (en) | 1998-12-30 |
| CA2292580A1 (en) | 1998-12-03 |
| RU2205829C2 (ru) | 2003-06-10 |
| AR012883A1 (es) | 2000-11-22 |
| NO995839L (no) | 2000-01-28 |
| DE69838716D1 (de) | 2007-12-27 |
| CN1191245C (zh) | 2005-03-02 |
| DE69838716T2 (de) | 2008-10-30 |
| JP4357598B2 (ja) | 2009-11-04 |
| IL133123A (en) | 2005-12-18 |
| AU732175B2 (en) | 2001-04-12 |
| CN1265659A (zh) | 2000-09-06 |
| DK0990654T3 (da) | 2008-01-21 |
| ES2297885T3 (es) | 2008-05-01 |
| EP0990654B1 (en) | 2007-11-14 |
| EP0990654A1 (en) | 2000-04-05 |
| MY119816A (en) | 2005-07-29 |
| BR9809702A (pt) | 2001-12-11 |
| ID23696A (id) | 2000-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5849757A (en) | Pyridonecarboxylic acid derivatives substituted by a bicyclic amino group as antibacterials | |
| JP4040091B2 (ja) | 置換アミノシクロアルキルピロリジン誘導体 | |
| US6184388B1 (en) | Substituted aminocycloalkylpyrrolidine derivatives and cis-substituted aminocycloalkylpyrrolidine derivatives | |
| US6586604B2 (en) | Tricyclic amine derivatives | |
| US6573260B1 (en) | Cycloalkyl-substituted aminomethylpyrrolidine derivatives | |
| JP4094061B2 (ja) | シス置換アミノシクロプロパン誘導体 | |
| EP0995744B1 (en) | Cis-substituted fluoromethylpyrrolidine derivatives | |
| NO318143B1 (no) | Substituerte cyklobutylamin-derivater samt farmasoytisk preparat | |
| RU2255938C2 (ru) | Производные аминометилпирролидина, имеющие ароматические заместители | |
| JP3833738B2 (ja) | 置換アミノメチルピロリジン誘導体 | |
| JPH10287669A (ja) | 置換アミノメチルピロリジン誘導体 | |
| JP3771620B2 (ja) | ヘテロ環式スピロ誘導体 | |
| MXPA99011056A (es) | Derivados de ciclobutilamina substituida | |
| JPH1081682A (ja) | シス置換アミノシクロプロパン誘導体 | |
| EP0816355A1 (en) | Heterocyclic spiro derivatives | |
| MXPA01005206A (es) | Derivados de aminometilpirrolidina cicloalquil-substituida |